It's hard out there for a rule-flouting, heavily financed disruptor. If it's not government regulators, then it's "frivolous lawsuits," amirite? This time, it's a class action lawsuit filed in California accusing 23andMe of "falsely and misleadingly" advertising their $99 genetic tests. The complaint, which asks for at least $5 million, also says the tests are "not supported by any scientific evidence."